A tale of two histiocytic disorders

about

BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease Cell-free DNA as a novel marker in cancer therapy.Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disorders.

P2860

Q33976971-E45BF51C-491D-4D02-89CB-F2B739479DBD Q38547170-70185187-E628-4604-A9B0-FFB2C7FC84DD Q40229747-E5DC1978-124B-402E-99A6-2DA43FF162DB

P2860

A tale of two histiocytic disorders

Item

http://www.wikidata.org/entity/Q36565617

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

A tale of two histiocytic disorders

@ast

A tale of two histiocytic disorders

@en

type

Item

label

A tale of two histiocytic disorders

@ast

A tale of two histiocytic disorders

@en

prefLabel

A tale of two histiocytic disorders

@ast

A tale of two histiocytic disorders

@en

P1476

A tale of two histiocytic disorders

@en

P2093

Javier Munoz

http://www.w3.org/2001/XMLSchema#string

Vivek Subbiah

http://www.w3.org/2001/XMLSchema#string

P2860

Recurrent BRAF mutations in Langerhans cell histiocytosis

Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial.

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Successful treatment of Erdheim-Chester disease, a non-Langerhans-cell histiocytosis, with interferon-alpha

Imatinib mesylate for platelet-derived growth factor receptor-beta-positive Erdheim-Chester histiocytosis

Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease

Response of histiocytoses to imatinib mesylate: fire to ashes

Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases

CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

P304

2-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/THEONCOLOGIST.2012-0440

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Razelle Kurzrock

Filip Janku

P577

2013-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234089408

http://www.w3.org/2001/XMLSchema#string

P698

23299771

http://www.w3.org/2001/XMLSchema#string

P932

3556250

http://www.w3.org/2001/XMLSchema#string

A tale of two histiocytic disorders

about

P2860

P2860

A tale of two histiocytic disorders

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932